La poliomyélite: une maladie neurologique provoquée par un virus entérotrope

Addair, 1942, Evidence for an autosomal recessive gene for susceptibility to paralytic poliomyelitis, J Hered, 33, 307, 10.1093/oxfordjournals.jhered.a105200 Agre, 1989, Symptoms and clinical impressions of patients seen in a post-polio clinic, Arch Phys Med Rehab, 70, 367 Almond, 1987, Studies on the attenuation of the Sabin type 3 oral polio vaccine, J Virol Methods, 17, 183, 10.1016/0166-0934(87)90081-4 Armstrong, 1939, Successful transfer of the Lansing strain of poliomyelitis wirus from cotton rats to the white mouse, Publ Hlth Rep, Washington, 54, 2302, 10.2307/4583135 Assaad, 1982, The relation between acute persisting paralysis and poliomyelitis vaccine-results of a ten-year inquiry, Bull WHO, 60, 231 Aycock, 1942, Familial aggregation in poliomyelitis, Am J Med Sci, 203, 452 Baker, 1989, Neuromuscular symptoms in patients with previous poliomyelitis: a New Zealand study, New Zealand Med J, 102, 132 Balanant, 1991, The natural genomic variability of poliovirus analyzed by a restriction fragment length polymorphism assay, Virology, 184, 645, 10.1016/0042-6822(91)90434-D Bijkerk, 1979, Poliomyelitis epidemic in the Netherlands, 1978, Dev Biol Standard, 43, 195 Blondel, 1983, De-tection by monoclonal antibodies of an antigenic determinant critical for poliovirus neutralization present on VP1 and on heat-inactivated, Virology, 126, 707, 10.1016/S0042-6822(83)80027-0 Bockman, 1973, Pinocytosis by epithelium associated with lymphoid follicles in the bursa of Fabricius, appendix and Peyer's patches, Am J Anat, 136, 455, 10.1002/aja.1001360406 Cammack, 1988, Intertypic genomic rearrangements of poliovirus strains in vaccinees, Virology, 167, 507, 10.1016/S0042-6822(88)90113-4 Cashman, 1988, Post-polio syndrome, Biomed Pharmacother, 42, 429 Center for Disease Control, 1994, Certification of poliomyelitis eradication-the Americas, 1994, Morb Mortal Wkly Rep, 43, 720 Christodoulou, 1990, Mapping of mutations associated with neurovirulence in monkeys infected with Sabin 1 poliovirus revertants selected at high temperature, J Virol, 64, 4922, 10.1128/JVI.64.10.4922-4929.1990 Cooper, 1977, Genetics of picornaviruses, Compr Virol, 9, 133 Couderc, 1990, Poliovirus permissivity and specific receptor expression on human endothelial cells, Virology, 174, 95, 10.1016/0042-6822(90)90058-Y Crainic, 1981, Determination of type 1 poliovirus subtype classes with neutralizing monoclonal antibodies, Dev Biol Standard, 50, 229 Crainic, 1993, Natural evolution of oral vaccine poliovirus strains Cuceanu N, Otelea D, Crainic R (1995) (résultats non publiés) Dalakas, 1986, New neuromuscular symtoms in patients with old poliomyelitis: a three year follow-up study, Eur Neurol, 25, 381, 10.1159/000116038 Dalakas, 1984, Late post-poliomyelitis muscular atrophy: clinical, virologic and immunologic studies, Rev Infect Dis, 6, 562, 10.1093/clinids/6.Supplement_2.S562 Dausset, 1975, Some contributions of the HL-A complex to the genetics of human diseases, Transplant Rev, 22, 44 de la Torre, 1992, High frequency of single-base transitions and extreme frequency of precise multiple-base reversion mutations in poliovirus, 89, 2531 De Quadros, 1993, Strategies for poliomyelitis eradication in developing countries, Public Health Rev, 21, 65 de Quadros, 1993, Disease eradication and control in the Americas, Biologicals, 21, 335, 10.1006/biol.1993.1093 Diard, 1994, French survey of postpolio sequelae. Risk factors study and medical social outcome, Am J Phys Med Rehabil, 73, 264, 10.1097/00002060-199407000-00007 Drake, 1993, Rates of spontaneous mutation among RNA viruses, 90, 4171 Emini, 1982, Poliovirus neutralization epitopes: analysis and localization with neutralizing monoclonal antibodies, J Virol, 43, 997, 10.1128/JVI.43.3.997-1005.1982 Fenner, 1988 Ferguson, 1982, Monoclonal antibodies specific for the Sabin vaccine strain of poliovirus 3, Lancet, 2, 122, 10.1016/S0140-6736(82)91091-1 Filman, 1989, Structural factors that control conformational transitions and serotypes specificity in type 3 poliovirus, EMBO J, 8, 1567, 10.1002/j.1460-2075.1989.tb03541.x Freistadt, 1993, Poliovirus receptor on human blood cells: a possible extraneural site of poliovirus replication, Virology, 195, 798, 10.1006/viro.1993.1433 Freistadt, 1990, Heterogeneous expression of poliovirus receptor-related proteins in human cells and tissues, Mol Cell Biol, 10, 5700, 10.1128/MCB.10.11.5700 Furione, 1993, Polioviruses with natural recombinant genomes isolated from vaccineassociated paralytic poliomyelitis, Virology, 196, 199, 10.1006/viro.1993.1468 Georgescu MM, Delpeyroux F, Crainic R (1995) (résultats non publiés) Ghalioungui, 1973, The house of life, 154 Guillot, 1994, Point mutations involved in the attenuation/neurovirulence alternation in type 1 and 2 oral polio vaccine strains detected by sitespecific, Vaccine, 12, 503, 10.1016/0264-410X(94)90307-7 Herndon, 1951, A twin family study of susceptible poliomyelitis, Am J Hum Genet, 3, 17 Hinman, 1988, Live or inactivated poliomyelitis vaccine: an analysis of benefits and risks, Am J Public Health, 78, 291, 10.2105/AJPH.78.3.291 Hirst, 1962, Genetic recombination with Newcastle virus, poliovi-83 ruses and influenza, 27, 303 Holland, 1961, Receptor affinities as major determinants of enterovirus tissue tropisms in Humans, Virology, 15, 312, 10.1016/0042-6822(61)90363-4 Holland, 1992, RNA virus populations as quasispecies, Curr Top Microbiol Immunol, 176, 1, 10.1007/978-3-642-77011-1_1 1989, The outbreak of poliomyelitis in Finland in 1984–1985: significance of antigenic variation of type 3 polioviruses and site specificity of, Adv Virus Res Hull, 1992, Progress towards the global eradication of poliomyelitis, World Health Stat Q, 45, 280 Hurst, 1936, The newer knowledge of virus diseases of the nervous system: a review and an interpretation, Brain, 59, 1, 10.1093/brain/59.1.1 Jubelt, 1993, Post-polio syndrome: an update, 13, 283 Kawamura, 1989, Determinants in the 5'noncoding region of poliovirus Sabin 1 RNA that influence the attenuation phenotype, J Virol, 63, 1302, 10.1128/JVI.63.3.1302-1309.1989 Kew, 1981, Multiple genetic changes can occur in the oral poliovaccines upon replication in humans, J Gen Virol, 10.1099/0022-1317-56-2-337 Koike, 1990, The poliovirus receptor protein is produced both as membrane-bound and secreted forms, Embo J, 9, 3217, 10.1002/j.1460-2075.1990.tb07520.x Koike, 1991, Transgenic mice susceptible to poliovirus, 88, 951 La Monica, 1989, Differences in replication of attenuated and neurovirulent polioviruses in human neuroblastoma cell line SH-SY5Y, J Virol, 63, 2357, 10.1128/JVI.63.5.2357-2360.1989 Lasch, 1979, Study of the HLA antigen in Arab children with paralytic poliomyelitis, Israel J Med Sci, 15, 12 Li, 1955, Experimentally produced variants of poliomyelitis virus combining in vivo and in vitro techniques, Ann NY Acad Sci, 61, 902, 10.1111/j.1749-6632.1955.tb42549.x Lipskaya, 1991, Frequent isolation of intertypic poliovirus recombinants with serotype 2 specificity from vaccine-associated polio cases, J Med Virol, 35, 290, 10.1002/jmv.1890350415 Lwoff, 1959, Factors inflencing the evolution of viral disease at the cellular level and in the organism, Bacteriol Rev, 23, 109, 10.1128/BR.23.3.109-124.1959 Macadam, 1989, Reversion of the attenuated and temperature-sensitive phenotypes of the Sabin type 3 strain of poliovirus in vaccinees, Virology, 172, 408, 10.1016/0042-6822(89)90183-9 Macadam, 1991, An assembly defect as a result of an attenuating mutation in the capsid proteins of the poliovirus type-3 vaccine strain, J Virol, 65, 5225, 10.1128/JVI.65.10.5225-5231.1991 Macadam, 1992, Correlation of RNA secondary structure and attenuation of Sabin vaccine strains of poliovirus in tissue culture, Virology, 189, 415, 10.1016/0042-6822(92)90565-7 Macadam, 1993, Genetic Basis of Attenuation of the Sabin type-2 vaccine strain of poliovirus in primates, Virology, 192, 18, 10.1006/viro.1993.1003 Martyn, 1988, Motoneuron disease and postpoliomyelitis in England and Wales, The Lancet, 1, 1319, 10.1016/S0140-6736(88)92129-0 McLaren, 1959, The mammalian cell-virus relationship. I. Attachement of poliovirus to cultivated cells of primate and non primate origin, J Exp Med, 109, 475, 10.1084/jem.109.5.475 Melnick, 1990, Enteroviruses Melnick, 1993, Lessons from poliofirus control strategies for eradication Mendelsohn, 1989, Cellular receptor for poliovirus: molecular cloning, nucleotide sequence, and expression of a new member of the immunoglobulin superfamily, Cell, 56, 855, 10.1016/0092-8674(89)90690-9 Miller, 1981, Prolonged intracerebral infection with poliovirus in asymptomatic mice, Ann Neurol, 9, 590, 10.1002/ana.410090613 Minor, 1992, The molecular biology of poliovaccines, J Gen Virol, 73, 3065, 10.1099/0022-1317-73-12-3065 Minor, 1989, The temperature sensitivity of the Sabin type 3 vaccine strain of poliovirus: molecular and structural effects of a mutation in the capsid, J Gen Virol, 70, 1117, 10.1099/0022-1317-70-5-1117 Munsat, 1991, Poliomyelitis new problems with an old disease, N Engl J Med, 324, 1206, 10.1056/NEJM199104253241709 Nakano, 1978, Parameters for differentiating vaccine-derived and wild poliovirus strains, Progr Med Virol, 24, 178 Nkowane, 1987, Vaccine-associated paralytic poliomyelitis. UnitedStates: 1973 through 1984, J Am Med Assoc, 257, 1335, 10.1001/jama.1987.03390100073029 Nomoto, 1982, Complete nucleotide sequence of the attenuated poliovirus Sabin 1 strain genome, 79, 5793 Ogra, 1991, Effect of prior immunity on the shedding of virulent revertant virus in feces after oral immunization with live attenuated poliovirus vaccines, J Infect Dis, 164, 191, 10.1093/infdis/164.1.191 Ogra, 1980, Viral vaccination via the mucosal routes. (Review), Rev Infect Dis, 2, 352, 10.1093/clinids/2.3.352 Omata, 1986, Genetic analysis of the attenuation phenotype of poliovirus type 1, J Virol, 58, 348, 10.1128/JVI.58.2.348-358.1986 Osterhaus, 1981, Monoclonal antibodies to polioviruses. Production of specific monoclonal antibodies to the Sabin vaccine strains, Intervirology, 16, 218, 10.1159/000149270 Otelea, 1993, Genomic modifications in naturally occurring neurovirulent revertants of Sabin 1 polioviruses, Dev Biol Stand, 78, 33 Owen, 1974, Epithelial cell specialization within human Peyer's patches: an ultrastructural study of intestinal lymphoid follicles, Gastroenterology, 66, 189, 10.1016/S0016-5085(74)80102-2 Patriarca, 1991, Factors affecting the immunogenicity of oral poliovirus vaccine in developing countries: review, Rev Infect Dis, 13, 926, 10.1093/clinids/13.5.926 Paul, 1951, Antibodies to three different antigenic types of poliomyelitis virus from North Alaskan Eskimos, Am J Hyg, 55, 402 Peart, 1949, An outbreak of ppoliomyelitis in Canadian Eskimos in winter time: epidemiologic features, Can J Public Health, 40 Pietsch, 1974, An association of HL-A3 and HL-A7 with paralytic poliomyelitis, Tissue Antigens, 4, 50, 10.1111/j.1399-0039.1974.tb00224.x Pollard, 1989, Nucleotide sequence of a neurovirulent variant of the type 2 oral poliovirus vaccine, J Virol, 63, 4949, 10.1128/JVI.63.11.4949-4951.1989 Reedy, 1957, Recessive inheritance to susceptibility to poliomyelitis in fifty pedigrees, J Hered, 48, 37, 10.1093/oxfordjournals.jhered.a106677 Ren, 1991, Identification of two determinants that attenuate vaccine-related type 2 poliovirus, J Virol, 65, 1377, 10.1128/JVI.65.3.1377-1382.1991 Ren, 1992, Poliovirus spreads from muscle to the central nervous system by neural pathways, J Infect Dis, 166, 747, 10.1093/infdis/166.4.747 Rico Hesse, 1987, Geographic distribution of wild poliovirus type 1 genotypes, Virology, 160, 311, 10.1016/0042-6822(87)90001-8 Roivainen, 1994, Hovit Twenty-one patients with strictly defined postpoliomyelitis syndrome: no poliovirus-specific IgM antibodies in the cerebrospinal fluid, Ann Neurol, 36, 115, 10.1002/ana.410360125 Sabin, 1951, Paralytic consequences of poliomyelitis infection in different parts of the world and in different population groups, Am J Public Health, 41, 1215, 10.2105/AJPH.41.10.1215 Sabin, 1957, Properties of attenuated polioviruses and their behaviour in human beings and Cellular biology, nucleic acids, and viruses, NY Acad Sci New York Sabin, 1965, Oral poliovirus vaccine. History of its development and prospects for eradication of poliomyelitis, J Am Med Assoc, 194, 872, 10.1001/jama.1965.03090210036010 Sabin, 1985, Oral poliovirus vaccine: history of its development and use and current challenge to eliminate poliomyelitis from the world, J Infect Dis, 151, 420, 10.1093/infdis/151.3.420 Sabin, 1973, Hystory of Sabin attenuated poliovirus oral vaccine strains, J Biol Standard, 1, 115, 10.1016/0092-1157(73)90048-6 Sabin, 1954, Studies of variants of poliomyelitis virus. I. Experimental segregation and properties of avirulent variants of three immunologic types, J Exp Med, 99, 551, 10.1084/jem.99.6.551 Salk, 1977, Control of influenza and poliomyelitis with killed virus vaccines. [Review], Science, 195, 834, 10.1126/science.320661 Salk, 1960, Persistence of immunity after administration of formalin-treated poliovirus vaccine, Lancet, ii, 715, 10.1016/S0140-6736(60)91791-8 Sharief, 1991, Intrathecal immune response in patients with the post-polio syndrome, N Engl J Med, 325, 749, 10.1056/NEJM199109123251101 Shepley, 1994, A monoclonal antibody that blocks poliovirus attachment recognizes the lymphocyte himing receptor CD44, J Virol, 68, 1301, 10.1128/JVI.68.3.1301-1308.1994 Sicinski, 1990, Poliovirus type 1 enters the human host through intestinal M cells, Gastroenterology, 98, 56, 10.1016/0016-5085(90)91290-M Slater, 1990, Poliomyelitis outbreak in Israel in 1988: a report with two commentaries, Lancet, 335, 1192, 10.1016/0140-6736(90)92705-M Stone, 1994, Post-polio syndrome: remembrance of viruses past, Science, 264, 909, 10.1126/science.8178150 Strebel, 1992, Epidemiology of poliomyelitis in the United States one decade after the last reported case of indigenous wild virus-associated disease, Clin Infect Dis, 14, 568, 10.1093/clinids/14.2.568 Svitkin, 1990, Translation deficiency of the Sabin type 3 poliovirus genome: association with an attenuating mutation C472 → U, Virology, 175, 103, 10.1016/0042-6822(90)90190-3 Swartz, 1993, Basic conditions for the eradication of poliomyelitis-indications for a common prescription, Public Health Rev, 21, 157 Tardy-Panit, 1993, A Mutation in the RNA Polymerase of Poliovirus Type-1 Contributes to Attenuation in Mice, J Virol, 67, 4630, 10.1128/JVI.67.8.4630-4638.1993 Tatem, 1992, A mutation present in the amino terminus of sabin-3 poliovirus VP1 protein is attenuating, J Virol, 66, 3194, 10.1128/JVI.66.5.3194-3197.1992 Terry, 1962, The association of cases of poliomyelitis with the use of type III oral poliomyelitis vaccine Toyoda, 1984, Complete nucleotide sequences of all three poliovirus serotype genomes. Implication for genetic relationship, gene function and antigenic, J Mol Biol, 174, 561, 10.1016/0022-2836(84)90084-6 Trojan, 1994, Predictive factors for post-poliomyelitis syndrome, Arch Phys Med Rehabil, 75, 770, 10.1016/0003-9993(94)90134-1 Tulchinsky, 1994, Successful control of poliomyelitis by a combined OPV/IPV polio vaccine program in the West Bank and Gaza, 1978-93, Isr J Med Sci, 30, 489 van Eden, 1983, Differential resistance to paralytic poliomyelitis controlled by histocompatibility leukocyte antigens, J Infect Dis, 147, 422, 10.1093/infdis/147.3.422 van Wijngaarden, 1993, The polio epidemic in TheNetherlands, 1992/1993, Public Health Rev, 21, 107 von Magnus, 1984, Vaccination with inactivated poliovirus vaccine and oral poliovirus vaccine in Denmark, Rev Infect Dis, 10.1093/clinids/6.Supplement_2.S471 Westrop, 1989, Genetic basis of attenuation of the Sabin type 3 oral poliovirus vaccine, J Virol, 63, 1338, 10.1128/JVI.63.3.1338-1344.1989 Windebank, 1991, Late effects of paralytic poliomyelitis in Olmsted County, Minnesota, Neurology, 41, 501, 10.1212/WNL.41.4.501 World Health Assembly, 1988 World Health Organization, 1980 World Health Organization, 1981, Poliomyelitis in 1980. Part 1 and 2, Week Epidemiol Rec, 56, 329 Wright, 1991, Strategies for the global eradication of poliomyelitis by the year 2000, N Engl J Med, 325, 1774, 10.1056/NEJM199112193252504 Wyatt, 1978, Abortive poliomyelitis or minor illness as a clue to genetic susceptibility, Med Microbiol Immunol, 166, 29, 10.1007/BF02121131 Zander, 1979, HLA-A,-B, and-D antigens in paralytic poliomyelitis, Tissue Antigens, 13, 310, 10.1111/j.1399-0039.1979.tb00800.x